OverviewSuggest Edit

Zynex is a company that designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. Its products include an electrical nerve stimulation device, and electromyography triggered an electrical stimulation device, as well as a device for the treatment of female urinary incontinence.
TypePublic
Founded1996
HQEnglewood, US
Websitezynex.com
Employee Ratings3.6

Latest Updates

Employees (est.) (Dec 2019)283(+56%)
Job Openings21
Revenue (FY, 2019)$45.5 M(+43%)
Share Price (Sept 2020)$17.2
Cybersecurity ratingAMore

Key People/Management at Zynex

Thomas Sandgaard

Thomas Sandgaard

Chairman of the Board, President and Chief Executive Officer
Dan Moorhead

Dan Moorhead

CFO
Joseph Papandrea

Joseph Papandrea

Chief Operating Officer
Chelle van Burkleo

Chelle van Burkleo

VP of Sales
Anna Lucsok

Anna Lucsok

VP of Reimbursement
Show more

Zynex Office Locations

Zynex has offices in Englewood and Lone Tree
Englewood, US (HQ)
9555 Maroon Cir
Lone Tree, US
9990 Park Meadows Dr
Show all (2)

Zynex Financials and Metrics

Zynex Revenue

Embed Graph
View revenue for all periods
Zynex's revenue was reported to be $45.47 m in FY, 2019
USD

Revenue (Q2, 2020)

19.3m

Gross profit (Q2, 2020)

15.2m

Gross profit margin (Q2, 2020), %

78.9%

Net income (Q2, 2020)

3.0m

EBIT (Q2, 2020)

4.1m

Market capitalization (18-Sept-2020)

596.9m

Closing stock price (18-Sept-2020)

17.2

Cash (30-Jun-2020)

16.9m

EV

585.5m
Zynex's current market capitalization is $596.9 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

34.1m39.7m21.7m11.1m11.6m13.3m23.4m31.9m45.5m

Cost of goods sold

7.4m8.8m8.1m4.2m4.9m3.5m4.8m6.0m8.8m

Gross profit

26.8m30.9m13.5m6.9m6.7m9.8m18.6m25.9m36.7m

Gross profit Margin, %

78%78%62%62%58%74%79%81%81%
Annual
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

374.0k965.0k320.0k793.0k1.2m(304.0k)(2.0m)(2.8m)(1.4m)(7.0m)(6.7m)2.9m6.0m

Depreciation and Amortization

389.0k594.0k213.0k432.0k647.0k213.0k417.0k647.0k156.0k309.0k469.0k252.0k537.0k

Inventories

(93.0k)(791.0k)(995.0k)(2.1m)(2.3m)(181.0k)123.0k(265.0k)(23.0k)400.0k186.0k(1.5m)(2.4m)

Accounts Payable

145.0k848.0k335.0k516.0k264.0k(382.0k)51.0k232.0k162.0k258.0k2.0k162.0k189.0k
USDQ2, 2011

Financial Leverage

2.1 x
Show all financial metrics

Zynex Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

Zynex Online and Social Media Presence

Embed Graph

Zynex News and Updates

Zynex, Inc. Prices Public Offering of Common Stock

ENGLEWOOD, Colo., July 14, 2020 /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological...

Zynex to Present at the Piper Jaffray 31st Annual Healthcare Conference

ENGLEWOOD, Colo., Dec. 2, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today...

Zynex Announces 95% Order Growth

ENGLEWOOD, Colo., Oct. 2, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today...

Zynex to Present at Raymond James Life Sciences and MedTech Conference

ENGLEWOOD, Colo., June 12, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today...

Zynex Announces Uplisting to The Nasdaq Capital Market

ENGLEWOOD, Colo., Feb. 7, 2019 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, is...

Zynex Announces 2018 Third Quarter Earnings and Special Dividend

ENGLEWOOD, Colo., Nov. 6, 2018 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today...
Show more

Zynex Frequently Asked Questions

  • When was Zynex founded?

    Zynex was founded in 1996.

  • Who are Zynex key executives?

    Zynex's key executives are Thomas Sandgaard, Dan Moorhead and Joseph Papandrea.

  • How many employees does Zynex have?

    Zynex has 283 employees.

  • What is Zynex revenue?

    Latest Zynex annual revenue is $45.5 m.

  • What is Zynex revenue per employee?

    Latest Zynex revenue per employee is $160.7 k.

  • Who are Zynex competitors?

    Competitors of Zynex include TAO Connect, Velano Vascular and Sana Health.

  • Where is Zynex headquarters?

    Zynex headquarters is located at 9555 Maroon Cir, Englewood.

  • Where are Zynex offices?

    Zynex has offices in Englewood and Lone Tree.

  • How many offices does Zynex have?

    Zynex has 2 offices.